The pneumococcal conjugate vaccine arrives: A big win for kids

Pediatric Infectious Disease Journal

Volumn 19, Issue 3, 2000, Pages 181-182

  Klein, Jerome O ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Pneumococcal conjugate vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

CHILD; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; NOTE; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

BACTERIAL VACCINES; HUMANS; INFANT; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0034122499     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200003000-00001     Document Type: Note

References (5)

1. Black S, Shinefield H, Fireman B, et al. Safety, immunogenicity and efficacy of heptavalent pneumococcal conjugate in infancy. Pediatr Infect Dis J 2000;19:000-00.
2. Wright AE, Morgan WP, Colebrook L, Dodgson RW. Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet 1914:1-10, 87-95.
3. Francis T Jr, Tillett WS. Cutaneous reactions in pneumonia: the development of antibodies following the intradermal injection of type-specific polysaccharide. J Exp Med 1930;52: 573-85.
4. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch Intern Med 1937;59:602.
5. MacLeod CM, Hodges RG, Heidelberger M, Berhard WG. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945;82: 445-65.